Zhengye Biotechnology Holding (ZYBT) Invested Capital: 2023-2025
- Zhengye Biotechnology Holding's Invested Capital was N/A to $61.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $61.7 million, marking a year-over-year change of. This contributed to the annual value of $58.5 million for FY2024, which is 1.36% down from last year.
- Per Zhengye Biotechnology Holding's latest filing, its Invested Capital stood at $61.7 million for Q2 2025, which was up 5.39% from $58.5 million recorded in Q4 2024.
- Over the past 5 years, Zhengye Biotechnology Holding's Invested Capital peaked at $61.7 million during Q2 2025, and registered a low of $58.2 million during Q4 2023.
- Moreover, its 3-year median value for Invested Capital was $58.5 million (2024), whereas its average is $59.5 million.
- Data for Zhengye Biotechnology Holding's Invested Capital shows a peak YoY grew of 0.49% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Zhengye Biotechnology Holding's Invested Capital stood at $58.2 million in 2023, then grew by 0.49% to $58.5 million in 2024, then reached $61.7 million in 2025.
- Its Invested Capital stands at $61.7 million for Q2 2025, versus $58.5 million for Q4 2024 and $58.2 million for Q4 2023.
